Motorcar Parts of America MPAA Income Tax Reconciliation Tax Credits Research And Development

Income Tax Reconciliation Tax Credits Research And Development at other companies

Ionis PharmaceuticalsIONS

$4.44M—

RBC BearingsRBC

$600K-4.0%

Lightpath TechnologiesLPTH

-$56.38K-49.5%

Wave Life SciencesWVE

-$1.24M—

Tectonic TherapeuticsTECX

$2.98M—

Teledyne TechnologiesTDY

0.4%0.0pp

Other financials

Income statement

See full

Revenue$212.3M+9.9%

Gross profit$50.4M+30.9%

Operating income$21.1M+29.4%

Net income$9.7M+1,447%

EPS (diluted)$0.49+1,325%

Balance sheet

See full

Cash & equivalents$14.7M+55.4%

Total debt$71.7M-10.0%

Total equity$266.0M+3.2%

Total assets$1.0B+6.5%

Cash flow

See full

Operating cash flow$21.9M-4.3%

CapEx$1.4M-49.5%

Free cash flow$20.8M-6.5%

Valuation

See full

Market cap$289.93M+38.0%

Enterprise value$346.98M+25.0%

P/E23.4×-103×

P/S0.4×+0.1×

Profitability

See full

Gross margin20.2%-0.1pp

Operating margin8.3%+3.1pp

Net margin1.6%+1.0pp

FCF margin8.9%+0.2pp

Returns & leverage

See full

Return on equity4.7%+3.0pp

Debt / equity0.3×0.0×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Motorcar Parts of America in its filing.

Tagged under the XBRL concept mpaa:IncomeTaxReconciliationTaxCreditsResearchAndDevelopment.

The official record: Motorcar Parts of America’s 10-K, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Motorcar Parts of America's income tax reconciliation tax credits research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Motorcar Parts of America's income tax reconciliation tax credits research and development?: Motorcar Parts of America (MPAA) reported income tax reconciliation tax credits research and development of $64K in Q1 2026.
What does income tax reconciliation tax credits research and development mean?: This metric represents the absolute dollar value of tax credits claimed by the company specifically for research and development activities. It reflects the company's ability to leverage government incentives to offset tax liabilities through innovation investment. Investors monitor this to gauge the tax-shield benefits derived from R&D spending.